Profile
ACOR ZTS TAK HLN TEVA NBIX
Company Name Acorda Therapeutics, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $821.03K $67.90B $47.69B $43.90B $22.86B $14.30B
Employees 0.10K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Ron Cohen Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
ACOR ZTS TAK HLN TEVA NBIX
Quant Rating Score 3 3 3 3 1 4
Quant Rating Neutral Neutral Neutral Neutral Strong Sell Buy
Trading
ACOR ZTS TAK HLN TEVA NBIX
Last Close $0.661 $148.2 $15.1 $9.81 $19.93 $141.87
High 52 $0.66 $196.48 $15.52 $11.41 $22.77 $153.29
Low 52 $0.66 $144.45 $12.89 $9.01 $12.82 $87.59
Price vs. 52 Week High 0.15 % -24.57 % -2.71 % -14.02 % -12.47 % -7.45 %
Price vs. 52 Week Low 0.15 % 2.6 % 17.15 % 8.88 % 55.46 % 61.97 %
Total Return
ACOR ZTS TAK HLN TEVA NBIX
1 Month Return 0 % -3.83 % 0.67 % 1.66 % 11.59 % 6.75 %
3 Month Return 0 % -9.82 % -0.66 % -9.75 % 17.3 % 14.05 %
6 Month Return 0 % -8.1 % 0.6 % -3.35 % 22.05 % 28.1 %
9 Month Return 0 % -16.83 % 12.52 % 0.51 % 20.79 % 11.97 %
YTD Return 0 % -9.04 % 14.05 % 2.83 % -9.57 % 3.93 %
1 Year Return 0 % -22.44 % 2.72 % -6.66 % 8.26 % 16.05 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACOR ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.26 % 4.36 % 0.02 % - -
Dividend Paid and Capex Coverage Ration (TTM) -52.97 % 1.89 % 2.03 % - 2.78 % 14.7 %
Dividend Per Share (TTM) - 1.93 % 196 % 0.06 % - -
Payout Ratio (TTM) - 32.08 % 226.17 % - - -
Profitability
ACOR ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 60.86 % 70.03 % 60.54 % 61.52 % 49.6 % 98.49 %
Return on Assets TTM -214.75 % 18.04 % 0.98 % 4.2 % -0.39 % 8.95 %
Return on Equity TTM 786.07 % 53.21 % 1.95 % 8.74 % -2.58 % 13.22 %
Return on Capital Employed TTM 21.14 % 31.67 % 3.43 % 7.74 % 3.16 % 14.8 %
Net Income Per EBT TTM 85.42 % 78.72 % 72.1 % 75.5 % 222.54 % 66.08 %
EBT Per Ebit TTM 1272.44 % 94.26 % 46.84 % 86.58 % -7.94 % 106.48 %
EBIT Per Revenue TTM -19.78 % 37.51 % 9.05 % 19.64 % 5.38 % 19.72 %
Cash Flow To Debt Ratio TTM -7.33 % 43.13 % 23.79 % - 7.93 % 129.2 %
Receivables Turnover TTM 6.8 6.09 6.59 5.9 4.67 4.21
Payables Turnover TTM 3.17 5.54 4.53 2.19 3.35 0.36
Inventory Turnover TTM 2.85 1.15 1.54 3.63 2.4 0.66
Fixed Asset Turnover TTM 1867.19 % 244.46 % 229.02 % 584.75 % 321.73 % 429.78 %
Asset Turnover TTM 99.9 % 64.82 % 31.99 % 32.73 % 41.43 % 64.53 %
Operating Cash Flow Per Share TTM -11.26 6.58 684.97 - 1.21 5.73
Free Cash Flow Per Share TTM -11.47 4.99 531.34 - 0.78 5.34
Cash Per Share TTM 2444.44 % 322.4 % 26788.97 % 24.05 % 188.4 % 985.45 %
Operating Cash Flow Sales Ratio TTM -11.89 % 31.21 % 23.92 % - 8.36 % 22.6 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.89 % 75.76 % 77.57 % - 64.03 % 93.2 %
Cash Flow Coverage Ratios TTM -7.33 % 43.13 % 23.79 % - 7.93 % 129.2 %
Price To Free Cash Flows Ratio TTM -0.06 30.6 8.44 - 25.45 27.05
Price To Operating Cash Flows Ratio TTM -0.06 23.28 6.56 - 16.3 25.16
Price Cash Flow Ratio TTM -0.06 23.28 6.56 - 16.3 25.16
Income Statement (TTM)
ACOR ZTS TAK HLN TEVA NBIX
Revenue $0.12B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0.07B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 60.86% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $0.01B $3.87B $1210.51B $2.51B $0.78B $0.64B
Net Income $-0.25B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -203.59 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
ACOR ZTS TAK HLN TEVA NBIX
Long Term Debt $0B $5.39B $4517.23B $8.54B $16.3B $0.46B
Total Liabilities $0.28B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $-0.16B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0B $10.8B $0.08B $0B $1.71B
Total Debt $0.19B $6.74B $5066.17B $10.1B $18.08B $0.46B
Total Assets $0.12B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
ACOR ZTS TAK HLN TEVA NBIX
Net Income $-0.25B $2.5B $107.93B $1.44B $-1.96B $0.34B
Inventory $-0B $-0.04B $-34.97B $0.22B $0.17B $-0.02B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $1057.18B $2.3B $1.25B $0.6B
Capital Expenditure $-0B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.97
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 3.35
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 8.12
ALVOW Alvotech 1.13
AMPH Amphastar Pharmaceuticals, Inc. 27.265
AMRX Amneal Pharmaceuticals, Inc. 9.795
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 98.84
APUS Apimeds Pharmaceuticals US, Inc 2.03
AQST Aquestive Therapeutics, Inc. 5.135
ASRT Assertio Holdings, Inc. 0.8098
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 15.185
AYTU Aytu BioPharma, Inc. 2.3
ETFs With Exposure to ACOR
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 325.89
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00001 144.68
VXF Vanguard Extended Market Index Fund 0 209.37
VSTCX Vanguard Strategic Small-Cap Equity Fund Investor Shares 0 43.44
IEIH iShares Evolved U.S. Innovative Healthcare ETF 0 34.1348
VTSAX Vanguard Total Stock Market Index Fund 0 157.86
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 158.47
VITSX Vanguard Total Stock Market Index Fund 0 157.89
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 158.48
VEMPX Vanguard Extended Market Index InstlPlus 0 391.07
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 296.18
Unlock